Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
miriam.lichtner@uniroma1.it
Miriam Lichtner
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
miriam.lichtner@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
INTERNAL AND EMERGENCY MEDICINE
2021
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
2021
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study
PLOS ONE
2021
Metastatic penile squamous cell carcinoma successfully treated with cemiplimab in an HIV patient
DERMATOLOGIC THERAPY
2021
Impact of joint management of a COVID-19 mother and her newborn on the virus transmission. A case report
VIROLOGY JOURNAL
2021
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)
JOURNAL OF TRANSLATIONAL MEDICINE
2021
Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity
ENDOCRINE
2021
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
JOURNAL OF TRANSLATIONAL MEDICINE
2021
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy. A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2020
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
JOURNAL OF IMMUNOLOGY RESEARCH
2020
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis
VIROLOGY JOURNAL
2020
IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ?
ANTIOXIDANTS & REDOX SIGNALING
2020
Is albumin predictor of mortality in COVID-19?
ANTIOXIDANTS & REDOX SIGNALING
2020
Nox2 activation in covid-19
REDOX BIOLOGY
2020
Major reduction of NKT cells in patients with severe COVID-19 pneumonia
CLINICAL IMMUNOLOGY
2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I)
DIABETES RESEARCH AND CLINICAL PRACTICE
2020
Diagnostic accuracy and interobserver variability of CO-RADS in patients with suspected coronavirus disease-2019: a multireader validation study
EUROPEAN RADIOLOGY
2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)
CARDIOVASCULAR DIABETOLOGY
2020
Is Albumin Predictor of Mortality in COVID-19?
ANTIOXIDANTS & REDOX SIGNALING
2020
Auricle perniosis as a manifestation of Covid-19 infection
DERMATOLOGIC THERAPY
2020
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Marcatori di risposta e modificazioni del pattern infiammatorio in una corte di pazienti con polmonite da SARS-Cov2 sottoposti al trattamento con farmaci immunomodulanti
Ruolo dell'immunità innata nell'infezione da SARS-COV2 in una corte di pazienti con polmonite da COVID: biomarkers e correlati clinici
Risposta immune innata e immuno-attivazione T in pazienti coinfetti HIV/HCV sottoposti a farmaci ad azione diretta anti HCV (DAA) Innate immunity and immune activation in HIV/HCV coinfected subjects undergoing DAA
- Impatto dell'eradicazione di HCV nel controllo dell'immunoattivazione residua in pazienti HIV/HCV coinfetti - HCV eradication in HIV/HCV co-infected patients: impact on residual immune-activation.
Immunità mucosale nella donna HIV positiva in terapia antiretrovirale efficace: biomarcatori e correlati clinici Mucosal Immunity in HIV-1 infected women undergoing effective antiretroviral therapy: biomarkers and clinical determinants
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma